Pyrazolotriazines as kinase inhibitors

Details for Australian Patent Application No. 2005217617 (hide)

Owner Schering Corporation

Inventors Guzi, Timothy J.; Paruch, Kamil

Agent Griffith Hack

Pub. Number AU-B-2005217617

PCT Pub. Number WO2005/082908

Priority 60/547,685 25.02.04 US

Filing date 23 February 2005

Wipo publication date 9 September 2005

Acceptance publication date 6 December 2007

International Classifications

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

31 August 2006 PCT application entered the National Phase

  PCT publication WO2005/082908 Priority application(s): WO2005/082908

6 December 2007 Application Accepted

  Published as AU-B-2005217617

3 April 2008 Standard Patent Sealed

16 September 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005217618-Continuous culture apparatus with mobile vessel, allowing selection of fitter cell variants

2005217616-Tracer-containing compositions